CASI Pharmaceuticals To Report Second Quarter 2020 Financial Results And Host Conference Call August 10, 2020
ROCKVILLE, Md. and BEIJING, Aug. 3, 2020 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the Company will host a conference call more...
Innovative Technological Advancements Improve Early Cancer Diagnoses
FinancialBuzz.com News Commentary New York, NY (8/3/2020) – Cancer biomarkers have gained significant importance in the drug-development process in recent years. In particular, microarray technologies provide analysis of tens of thousands of molecules for a more...
ASLAN Pharmaceuticals Appoints Kenneth Kobayashi, MD, as Chief Medical Officer
SINGAPORE, Aug. 03, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Kenneth Kobayashi more...
VAALCO Schedules Second Quarter 2020 Earnings Release and Conference Call
HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY; LSE: EGY) today announced the timing of its second quarter 2020 earnings release and conference call. The Company will issue its second quarter more...
Celyad Oncology to Announce First Half 2020 Financial Results and Host Conference Call
MONT-SAINT-GUIBERT, Belgium, Aug. 03, 2020 (GLOBE NEWSWIRE) — Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for more...
5 Top Weekly TSX Stocks: Mawson Receives Funding, Jumps 43 Percent
The S&P/TSX Composite Index (INDEXTSI:OSPTX) was trending downward early on Friday (July 31), but ultimately closed the day at 16,181.39, up from Monday’s (July 27) open of 16,076.33. The index was under pressure following the more...
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm
SAN DIEGO, Aug. 2, 2020 /PRNewswire/ — Johnson Fistel, LLP, announces that class action lawsuits have been commenced on behalf of shareholders of the publicly-traded companies listed below. The Private Securities Litigation Reform Act of more...
CEMI LOSS NOTICE: ROSEN, A LEADING FIRM, Reminds Chembio Diagnostics, Inc. Investors of Important August 17 Deadline in Securities Class Action Seeking Recovery of Investor Losses- CEMI
NEW YORK, NY / ACCESSWIRE / August 2, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Chembio Diagnostics, Inc. (NASDAQ:CEMI) between March 12, 2020 and June more...